AMPH Stock: Amphastar Pharmaceuticals, Inc. Stock Price, Analysis & Insights
Get live AMPH stock price $20.16, comprehensive Amphastar Pharmaceuticals, Inc. stock analysis, charts, news, and expert forecast. Real-time AMPH stock data and investment insights.
Loading chart data...
Amphastar Pharmaceuticals, Inc. (AMPH) Overview
Amphastar Pharmaceuticals, Inc. (AMPH) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, AMPH trades at $20.16 with a market capitalization of 888.91M . Over the past 52 weeks, AMPH has traded between $16.65 and $31.26 , with the current price positioned at approximately 24% of th...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 888.91M
- Current price: $20.16
- 52-week range: $16.65 - $31.26
- P/E ratio: 12.14
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and p...
Company Information
- CEO
- Yongfeng Zhang
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 2028
Contact Information
- Website
- https://www.amphastar.com
- Address
- 11570 6th Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 12.1)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Amphastar Pharmaceuticals, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Amphastar Pharmaceuticals, Inc.
- ⚠Investors should consider how Amphastar Pharmaceuticals, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
888.91M
P/E Ratio (TTM)
12.14
Beta
0.90
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare AMPH with peer companies:
- Price
- $9.96
- Market cap
- 1.35B
- Price
- $14.03
- Market cap
- 625.20M
- Price
- $34.61
- Market cap
- 1.12B
- Price
- $4.66
- Market cap
- 1.05B
- Price
- $15.50
- Market cap
- 1.82B
- Price
- $3.22
- Market cap
- 190.96M
- Price
- $36.87
- Market cap
- 1.37B
- Price
- $89.00
- Market cap
- 1.31B
- Price
- $23.41
- Market cap
- 920.64M
- Price
- $17.73
- Market cap
- 1.57B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.